Title |
The Combination of Insulin-Like Growth Factor Receptor 1 (IGF1R) Antibody Cixutumumab and Mitotane as a First-Line Therapy for Patients with Recurrent/Metastatic Adrenocortical Carcinoma: a Multi-institutional NCI-Sponsored Trial
|
---|---|
Published by |
Springer Nature, May 2014
|
DOI | 10.1007/s12672-014-0182-1 |
Pubmed ID | |
Authors |
Antonio M. Lerario, Francis P. Worden, Carole A. Ramm, Elizabeth A. Hasseltine, Walter M. Stadler, Tobias Else, Manisha H. Shah, Edem Agamah, Krishna Rao, Gary D. Hammer |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 76 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Brazil | 1 | 1% |
Unknown | 75 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 10 | 13% |
Student > Bachelor | 9 | 12% |
Student > Doctoral Student | 9 | 12% |
Researcher | 8 | 11% |
Student > Master | 7 | 9% |
Other | 9 | 12% |
Unknown | 24 | 32% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 21 | 28% |
Agricultural and Biological Sciences | 6 | 8% |
Nursing and Health Professions | 5 | 7% |
Biochemistry, Genetics and Molecular Biology | 3 | 4% |
Psychology | 3 | 4% |
Other | 8 | 11% |
Unknown | 30 | 39% |